Fullbright Scholar in Cancer Clinical and Translational Research

Deadline: August 1, 2014

The competition for Fullbright Scholars for the 2015-2016 academic year launched in February, and this year Belgium is offering a Postdoctoral-Junior Research Award in Cancer Clinical and Translational Research. This opportunity is open to early-career academics and appropriately qualified professionals outside of academia, including but not limited to economists interested in health technology assessment, epidemiologists, bioinformaticians, physicians, statisticians, and molecular biologists with a specialization in genomics. A PhD is not required, and while some knowledge of French/Dutch would be useful, English is sufficient.

The selected candidate will spend twelve months at the European Organization for Research and Treatment of Cancer (EORTC), a leading cancer therapy and research center based in Brussels. He/she will receive training in the methodology of cancer clinical and translational research using data from EORTC databases, as well as gain valuable hands-on experience writing, performing, and managing drug development clinical trials. He/she will also be in direct contact with key opinion leaders in Brussels. A complete award description, profile of EORTC, and list of application requirements can be found here in the catalog of awards.

More information about the Fulbright Scholar Program can be found on the website, http://www.cies.org/, and the complete catalog can be accessed online at http://catalog.cies.org/. As outlined in the Eligibility Guidelines, all applicants must be U.S. citizens at the time of application.